Robert E. Litman

3.0k total citations
87 papers, 2.1k citations indexed

About

Robert E. Litman is a scholar working on Clinical Psychology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Robert E. Litman has authored 87 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Clinical Psychology, 31 papers in Psychiatry and Mental health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Robert E. Litman's work include Schizophrenia research and treatment (26 papers), Suicide and Self-Harm Studies (22 papers) and Treatment of Major Depression (8 papers). Robert E. Litman is often cited by papers focused on Schizophrenia research and treatment (26 papers), Suicide and Self-Harm Studies (22 papers) and Treatment of Major Depression (8 papers). Robert E. Litman collaborates with scholars based in United States, Germany and France. Robert E. Litman's co-authors include David Pickar, Norman L. Farberow, Edwin S. Shneidman, Walter W. Hong, William Z. Potter, Thomas R. Clem, Daniel W. Hommer, Kelly Papadakis, Tung‐Ping Su and Ronald W. Maris and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

Robert E. Litman

85 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert E. Litman United States 27 924 843 315 225 205 87 2.1k
A. Roy United States 24 579 0.6× 1.1k 1.2× 301 1.0× 327 1.5× 135 0.7× 33 1.8k
B. Jones Canada 20 1.4k 1.5× 569 0.7× 239 0.8× 223 1.0× 106 0.5× 47 2.1k
Jiří Raboch Czechia 24 655 0.7× 1.0k 1.2× 184 0.6× 199 0.9× 306 1.5× 117 2.2k
Cesario Bellantuono Italy 25 591 0.6× 766 0.9× 180 0.6× 461 2.0× 126 0.6× 97 2.1k
G Invernizzi Italy 23 1.2k 1.2× 589 0.7× 219 0.7× 206 0.9× 107 0.5× 71 2.1k
Martin M. Katz United States 26 998 1.1× 800 0.9× 259 0.8× 354 1.6× 96 0.5× 49 2.4k
Hans‐Jürgen Möller Germany 23 1.2k 1.3× 657 0.8× 302 1.0× 299 1.3× 232 1.1× 65 2.6k
Sam Tyano Israel 24 824 0.9× 907 1.1× 315 1.0× 228 1.0× 124 0.6× 72 2.0k
J.C. Ballenger United States 19 846 0.9× 809 1.0× 441 1.4× 240 1.1× 156 0.8× 196 2.2k
Jerónimo Sáiz-Ruiz Spain 26 869 0.9× 854 1.0× 221 0.7× 109 0.5× 136 0.7× 71 2.0k

Countries citing papers authored by Robert E. Litman

Since Specialization
Citations

This map shows the geographic impact of Robert E. Litman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Litman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Litman more than expected).

Fields of papers citing papers by Robert E. Litman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert E. Litman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Litman. The network helps show where Robert E. Litman may publish in the future.

Co-authorship network of co-authors of Robert E. Litman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert E. Litman. A scholar is included among the top collaborators of Robert E. Litman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert E. Litman. Robert E. Litman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walling, David P., Ying Dong, Robert E. Litman, et al.. (2024). Pharmacokinetics and Safety of a Novel Extended‐Release Microsphere Formulation of Risperidone in Patients with Schizophrenia or Schizoaffective Disorder. The Journal of Clinical Pharmacology. 65(3). 340–349. 2 indexed citations
2.
O’Donnell, Patricio, Mahnaz Asgharnejad, Xiaoming Du, et al.. (2023). The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial. Neuropsychopharmacology. 48(7). 1052–1059. 34 indexed citations
3.
Litman, Robert E., et al.. (2023). Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM. Neuropsychiatric Disease and Treatment. Volume 19. 219–232. 9 indexed citations
4.
Correll, Christoph U., et al.. (2020). Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation. Schizophrenia. 6(1). 37–37. 25 indexed citations
5.
Vanover, Kimberly E., Robert E. Davis, Yun Zhou, et al.. (2018). Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia. Neuropsychopharmacology. 44(3). 598–605. 58 indexed citations
6.
7.
Litman, Robert E., Mark A. Smith, James Doherty, et al.. (2016). AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study. Schizophrenia Research. 172(1-3). 152–157. 66 indexed citations
8.
Pickar, David, Robert E. Litman, P. Eric Konicki, Owen M. Wolkowitz, & Alan Breier. (2015). Neurochemical and Neural Mechanisms of Positive and Negative Symptoms in Schizophrenia. PubMed. 24. 124–151. 4 indexed citations
9.
Durgam, Suresh, Robert E. Litman, Kelly Papadakis, et al.. (2015). Cariprazine in the treatment of schizophrenia. International Clinical Psychopharmacology. 31(2). 61–68. 57 indexed citations
10.
Litman, Robert E., et al.. (2014). The Selective Neurokinin 3 Antagonist AZD2624 Does Not Improve Symptoms or Cognition in Schizophrenia. Journal of Clinical Psychopharmacology. 34(2). 199–204. 29 indexed citations
11.
Kramer, Michelle, Robert E. Litman, David Hough, et al.. (2009). Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study. The International Journal of Neuropsychopharmacology. 13(5). 635–647. 140 indexed citations
12.
Potkin, Steven G., Robert E. Litman, Rosarelis Torres, & Curt D. Wolfgang. (2008). Efficacy of Iloperidone in the Treatment of Schizophrenia. Journal of Clinical Psychopharmacology. 28(2). S4–S11. 66 indexed citations
13.
Litman, Robert E.. (1996). Suicidology: A Look Backward and Ahead. Suicide and Life-Threatening Behavior. 26(1). 1–7. 20 indexed citations
14.
Litman, Robert E., Tung‐Ping Su, William Z. Potter, Walter W. Hong, & David Pickar. (1996). Idazoxan and Response to Typical Neuroleptics in Treatment-Resistant Schizophrenia. The British Journal of Psychiatry. 168(5). 571–579. 110 indexed citations
15.
Litman, Robert E.. (1995). Suicide Prevention in a Treatment Setting. Suicide and Life-Threatening Behavior. 25(1). 134–142. 16 indexed citations
16.
Silverman, Morton M., Alan L. Berman, Bruce Bongar, Robert E. Litman, & Ronald W. Maris. (1994). Inpatient Standards of Care and the Suicidal Patient Part II: An Integration with Clinical Risk Management. Suicide and Life-Threatening Behavior. 24(2). 152–169. 32 indexed citations
17.
Litman, Robert E., Daniel W. Hommer, Allen D. Radant, Thomas R. Clem, & David Pickar. (1994). Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia. Schizophrenia Research. 12(2). 107–120. 46 indexed citations
18.
Litman, Robert E.. (1991). Predicting and Preventing Hospital and Clinic Suicides. Suicide and Life-Threatening Behavior. 21(1). 56–73. 12 indexed citations
19.
Hommer, Daniel W., Thomas R. Clem, Robert E. Litman, & David Pickar. (1991). Maladaptive anticipatory saccades in schizophrenia. Biological Psychiatry. 30(8). 779–794. 52 indexed citations
20.
Farberow, Norman L., et al.. (1988). Youth suicide in California: A comparative study of perceived causes and interventions. Community Mental Health Journal. 24(1). 31–42. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Roy Breakdown of academic impact, for papers by B. Jones Breakdown of academic impact, for papers by Jiří Raboch Breakdown of academic impact, for papers by Cesario Bellantuono Breakdown of academic impact, for papers by G Invernizzi Breakdown of academic impact, for papers by Martin M. Katz Breakdown of academic impact, for papers by Hans‐Jürgen Möller Breakdown of academic impact, for papers by Sam Tyano Breakdown of academic impact, for papers by J.C. Ballenger Breakdown of academic impact, for papers by Jerónimo Sáiz-Ruiz
Rankless by CCL
2026